Placebo tribulations [11] (multiple letters)

CMAJ. Canadian Medical Association Journal

Volumn 167, Issue 5, 2002, Pages 455-457

  Grenier, Glenn G ^a   Corman, Jack ^a   Blajchman, Morris A ^a   Knight, Allan ^a   Buchanan, W Watson ^a   Weijer, Charles ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

BIOAVAILABILITY; DIABETES MELLITUS; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL RESEARCH; STANDARD; UNIVERSITY HOSPITAL; BIOMEDICAL AND BEHAVIORAL RESEARCH; CANADA; CLINICAL TRIAL; ETHICS; NOTE; HEALTH CARE POLICY; TRI-COUNCIL POLICY STATEMENT ON ETHICAL CONDUCT FOR RESEARCH INVOLVING HUMANS;

BIOMEDICAL AND BEHAVIORAL RESEARCH; TRI-COUNCIL POLICY STATEMENT ON ETHICAL CONDUCT FOR RESEARCH INVOLVING HUMANS;

CANADA; CLINICAL TRIALS; ETHICS; HOSPITALS, UNIVERSITY; HUMANS; PLACEBOS; HEALTH POLICY;

EID: 0037015095     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)